BWVI Blue Water Ventures International

Blue Water Ventures International and Endurance Exploration Group Announce First Day Success on Steamboat North Carolina

Blue Water Ventures International and Endurance Exploration Group Announce First Day Success on Steamboat North Carolina

Jacksonville, FL, Oct. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (OTCPK: BWVI) and Endurance Exploration Group, Inc. (OTCPK: EXPL) announced today that several months of archaeological field work, including magnetometer surveys, has been performed on the 1840 wreck of the Steamship North Carolina. In late September BWVI recovery vessel, the Blue Water Rose, and dive team arrived on site to commence recovery efforts.  Gold coins, marble, dinnerware, and brass spikes, used in the ship’s construction, were among the first shipwreck items to be found.  Recovery efforts will continue as weather permits during the months of October and November.

The Steamship North Carolina sank the in the early morning of July 25, 1840, after colliding with its sister ship the Governor Dudley.  All passengers and crew from the North Carolina were transferred to the Governor Dudley within minutes of the collision without loss of lives.  However, passenger baggage and ship’s cargo were lost in the sinking.   It has been estimated that the hard currency lost on the SS North Carolina would be worth many millions of dollars in today’s value. 

It is believed that some gold coins from the newly commissioned US Mint in Dahlonega in 1838 would have been in circulation prior to the sinking of the SS North Carolina in 1840, and if found, these coins would be extremely valuable in today’s collectors’ market.  

Keith Webb, President BWVI, commented, “After working the first half of the 2019 dive season on several wreck sites, some famous, some not, with the goal of future admiralty claims, it’s great to be back in recovery mode on the SS North Carolina, especially when you see gold coins the very first day on site!”  

The Blue Water magnetometer survey team will now relocate to the SS Pulaski site, to remap the area.  After several trips to the Pulaski site, it has been revealed that the 2018 hurricane season shifted sand and the debris field.  In order to use resources efficiently, the BWVI team feels a thorough, updated survey of the area is required. 

About Blue Water Ventures International, Inc.:

The Company is engaged in the business of conducting archaeologically sensitive recoveries of cargo and artifacts from shipwrecks. Its operations to date have focused on shallow water search and recovery projects in less than 150 feet of water. The Company is now expanding its focus to include deep-water salvage of historic and modern-day shipwrecks. For more information go to 

About Endurance Exploration Group, Inc.:

Endurance Exploration Group, Inc. specializes in historic shipwreck research, subsea search, survey and recovery of lost ship containing valuable cargoes. Over the last 5 years, Endurance has developed a research database of over 1,400 ships that are known to be lost with valuable cargoes in the world oceans. For more information go to .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. Such forward-looking statements are subject to certain risks and uncertainties including, but not limited to ability to further strengthen our balance sheet, ability to raise funding for continued operations, ability to successfully and profitably locate additional wrecks and cargo, ability to establish ownership, and other factors. Therefore, actual results may differ materially from those indicated or implied by such forward-looking statements. Except as required by law, the Company disclaims any obligation to publicly update such statements.

Contact

Blue Water Ventures International, Inc.

Keith Webb

(904) 215-7601      

                                                                        

Endurance Exploration Group, Inc.

Micah Eldred

(727) 502-0508

EN
02/10/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Blue Water Ventures International

 PRESS RELEASE

Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick...

Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab Doblin commented on the potential of the company’s NeuroDirect™ ketamine topical cream to help those suffering from PTSD Psycheceutical Chief Visionary Officer Zappy Zapolin and CEO Chad Harman with MAPS Founder Rick Doblin MIAMI, March 29, 2023 (GLOBE NEWSWIRE) -- ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for the next generation of mental health treatments, hosted Rick Doblin, the Founder and Preside...

 PRESS RELEASE

Psycheceutical Bioscience, Inc. Announces Observational Research Resul...

Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of applying NeuroDirect™ ketamine topical creamPatients indicated their thought processes were clearer and more focused, and were more keenly aware of surroundings MIAMI, March 21, 2023 (GLOBE NEWSWIRE) -- ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge tec...

 PRESS RELEASE

Psycheceutical to Conduct the First Ever Phase I and II Clinical Trial...

Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD Psycheceutical ​​enters into agreement with iNGENū to conduct ​human ​clinical trials of NeuroDirect™ ketamine topical ​in AustraliaPhase I trial will study 20 people to test the safety, tolerability, and pharmacokinetics of a single dose of NeuroDirect™ ketaminePhase II trial will study 115 participants with PTSD and look at the effectiveness of NeuroDirect™ ketamine on improving their symptoms MIAMI, Feb. 15, 2023 (GLOBE NEWSWIRE) -- (OTCPK: BWVI) ("Psycheceutical"...

 PRESS RELEASE

Psycheceutical Announces Completion of Pre-IND Meeting with FDA for To...

Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD Company intends to pursue 505(b)(2) regulatory pathway for novel topical formulation of ketamine for the treatment of PTSD MIAMI, Feb. 02, 2023 (GLOBE NEWSWIRE) -- (OTCPK: BWVI) ("Psycheceutical" or the "Company"), a bioscience company dedicated to developing cutting-edge brain delivery technologies for the next generation of mental health treatments, is pleased to announce it has completed its pre-Investigational New Drug ("IND") meeting with the U.S. Food and Drug Administration (F...

 PRESS RELEASE

Psycheceutical Bioscience Provisional Patent Application for Novel Ket...

Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD Topical ketamine formulations could improve the methods of treating post-traumatic stress disorder (PTSD) MIAMI, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge treatments for mental health, has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) for the first ketamine topical intended for treating post-traumatic stress disorder (PTSD). The...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch